|
Never Give Up
Cancer
Journal, Educational Resources, Advocacy Information
Contact: Stephen Michael Apatow:
Founder, Director of Research and Development, Humanitarian
Resource Institute (UN:NGO:DESA) and the United Nations Arts Initiative.
Cancer
Research & Development
In
The Spotlight
Stephen Michael Apatow,
Founder of Humanitarian
Resource Institute, United Nations Arts Initiative, Director of
Research
and Development, Humanitarian
University Consortium Graduate Studies
Center
for Medicine, Veterinary Medicine and Law is working to engage every
level of the international biodefense, veterinary public health and the
medical research community into cancer treatment and prevention.
Today, his objective is to establish Tumor Infiltrating Lymphocyte
Therapy as a standard of care in conjunction with with advanced
diagnostics and treatment:
Tumor
Infiltrating Lymphocyte Therapy: A
specific type of cell transfer immunotherapy, in which the lymphocytes
infused back into the patient are from the patients own tumor.
These
lymphocytes are actually infiltrating and trying to destroy the tumor
and
they are obtained when the tumor is biopsied or excised. The tumor
infiltrating
lymphocytes contain a large concentration of cytotoxic T lymphocytes
specifically
targeted against the antigens in the patients own tumor as well as
numbers
of natural killer lymphoctes that can destroy tumor cells . The
lymphocytes
are grown in a laboratory with interleukin-2 to stimulate growth of the
lymphocytes and then infused back into the patient to attack and
destroy
the tumor. -- Neoplastic Disease: An Introduction to Human
Disease: Pathology and Pathophysiology Correlations, Leonard V. Crowley.
In patients with high grade
glioma, little is known regarding existence of naturally occurring
adaptive T cell reactivity against glioma-associated antigens (GAAs).
In this report, we characterized GAA-specific CD8+ T cells
and innate immune cells in a patient who has survived with anaplastic
astrocytoma (AA) for over 12 years without recurrence. -- Spontaneous immune responses against glioma-associated
antigens in a long term survivor with malignant glioma: Journal
of
Translational Medicine 2007, 5:68.
(Full
Text).
Related
Veterinary: Biologics,
Anti-Cancer Research
- Bioniche:
Mycobacterial
Cell Wall-DNA complex (MCC), Oligonucleotides.
Industry
Human Medicine: Anti-Cancer Research
|
